Marshall & Sullivan’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.31M | Buy |
8,876
+56
| +0.6% | +$26.1K | 2% | 24 |
|
|
2025
Q2 | $3.58M | Buy |
8,820
+171
| +2% | +$71.5K | 1.72% | 26 |
|
|
2025
Q1 | $4.3M | Sell |
8,649
-135
| -2% | -$73.1K | 2.18% | 28 |
|
|
2024
Q4 | $4.57M | Buy |
8,784
+38
| +0.4% | +$20.9K | 2.23% | 23 |
|
|
2024
Q3 | $5.41M | Sell |
8,746
-217
| -2% | -$128K | 2.6% | 18 |
|
|
2024
Q2 | $4.96M | Sell |
8,963
-10
| -0.1% | -$5.73K | 2.48% | 20 |
|
|
2024
Q1 | $5.22M | Sell |
8,973
-17
| -0.2% | -$9.54K | 2.58% | 19 |
|
|
2023
Q4 | $4.77M | Buy |
8,990
+42
| +0.5% | +$20.3K | 2.52% | 21 |
|
|
2023
Q3 | $4.53M | Sell |
8,948
-64
| -0.7% | -$34.1K | 2.64% | 21 |
|
|
2023
Q2 | $4.7M | Buy |
9,012
+17
| +0.2% | +$9.17K | 2.63% | 20 |
|
|
2023
Q1 | $5.18M | Sell |
8,995
-425
| -5% | -$240K | 3.14% | 13 |
|
|
2022
Q4 | $5.19M | Sell |
9,420
-388
| -4% | -$206K | 3.25% | 13 |
|
|
2022
Q3 | $4.97M | Sell |
9,808
-23
| -0.2% | -$12.9K | 3.44% | 11 |
|
|
2022
Q2 | $5.34M | Sell |
9,831
-63
| -0.6% | -$34.7K | 3.25% | 11 |
|
|
2022
Q1 | $5.84M | Sell |
9,894
-25
| -0.3% | -$14.4K | 3.26% | 12 |
|
|
2021
Q4 | $6.62M | Sell |
9,919
-251
| -2% | -$157K | 3.19% | 13 |
|
|
2021
Q3 | $5.81M | Sell |
10,170
-91
| -0.9% | -$49.9K | 3.03% | 15 |
|
|
2021
Q2 | $5.18M | Buy |
10,261
+110
| +1% | +$51.9K | 2.87% | 14 |
|
|
2021
Q1 | $4.63M | Buy |
10,151
+5,460
| +116% | +$2.61M | 2.79% | 17 |
|
|
2020
Q4 | $10.1K | Sell |
4,691
-5,397
| -53% | -$2.53M | 1% | 26 |
|
|
2020
Q3 | $4.45M | Sell |
10,088
-328
| -3% | -$136K | 3% | 18 |
|
|
2020
Q2 | $3.77M | Sell |
10,416
-779
| -7% | -$261K | 2.76% | 21 |
|
|
2020
Q1 | $3.17M | Sell |
11,195
-940
| -8% | -$296K | 2.82% | 20 |
|
|
2019
Q4 | $3.94M | Sell |
12,135
-571
| -4% | -$173K | 2.7% | 20 |
|
|
2019
Q3 | $3.7M | Buy |
12,706
+5
| +0% | +$1.43K | 2.72% | 18 |
|
|
2019
Q2 | $3.73M | Sell |
12,701
-161
| -1% | -$44.3K | 2.63% | 19 |
|
|
2019
Q1 | $3.52M | Sell |
12,862
-58
| -0.4% | -$14.4K | 2.59% | 20 |
|
|
2018
Q4 | $2.89M | Sell |
12,920
-540
| -4% | -$127K | 2.51% | 20 |
|
|
2018
Q3 | $3.29M | Buy |
13,460
+54
| +0.4% | +$12.4K | 2.39% | 20 |
|
|
2018
Q2 | $2.78M | Buy |
13,406
+361
| +3% | +$76.6K | 2.57% | 19 |
|
|
2018
Q1 | $2.69M | Sell |
13,045
-755
| -5% | -$158K | 2.19% | 23 |
|
|
2017
Q4 | $2.62M | Sell |
13,800
-9
| -0.1% | -$1.72K | 2.09% | 23 |
|
|
2017
Q3 | $2.68M | Sell |
13,809
-51
| -0.4% | -$9.24K | 2.48% | 20 |
|
|
2017
Q2 | $2.42M | Sell |
13,860
-69
| -0.5% | -$11.6K | 2.08% | 22 |
|
|
2017
Q1 | $2.4M | Buy |
13,929
+626
| +5% | +$95.7K | 2.08% | 21 |
|
|
2016
Q4 | $1.88M | Sell |
13,303
-183
| -1% | -$27K | 2.28% | 21 |
|
|
2016
Q3 | $2.15M | Sell |
13,486
-51
| -0.4% | -$7.86K | 2.76% | 18 |
|
|
2016
Q2 | $2M | Sell |
13,537
-316
| -2% | -$46.6K | 2.58% | 20 |
|
|
2016
Q1 | $1.96M | Buy |
13,853
+197
| +1% | +$26.4K | 2.49% | 19 |
|
|
2015
Q4 | $1.94M | Sell |
13,656
-93
| -0.7% | -$12.4K | 2.56% | 20 |
|
|
2015
Q3 | $1.85M | Buy |
13,749
+229
| +2% | +$29.8K | 2.42% | 21 |
|
|
2015
Q2 | $1.75M | Buy |
13,520
+239
| +2% | +$31.2K | 2.36% | 24 |
|
|
2015
Q1 | $1.78M | Sell |
13,281
-46
| -0.3% | -$5.93K | 2.29% | 23 |
|
|
2014
Q4 | $1.67M | Sell |
13,327
-568
| -4% | -$69.1K | 2.07% | 26 |
|
|
2014
Q3 | $1.69M | Buy |
13,895
+2,983
| +27% | +$363K | 2.38% | 24 |
|
|
2014
Q2 | $1.29M | Sell |
10,912
-141
| -1% | -$16.6K | 2.15% | 23 |
|
|
2014
Q1 | $1.33M | Sell |
11,053
-583
| -5% | -$69.3K | 2.4% | 22 |
|
|
2013
Q4 | $1.3M | Sell |
11,636
-859
| -7% | -$85.4K | 2.38% | 23 |
|
|
2013
Q3 | $1.15M | Sell |
12,495
-53
| -0.4% | -$4.79K | 2.15% | 24 |
|
|
2013
Q2 | $1.06M | Buy |
+12,548
| New | +$1.04M | 2.15% | 22 |
|
Other funds holding TMO
Marshall & Sullivan's TMO Position: Q3 2025 in Review
Marshall & Sullivan increased its Thermo Fisher Scientific (TMO) stake by 0.63% in Q3 2025, buying an estimated $26.1K and bringing the position to 8,876 shares worth $4.31M. The position accounts for 2% of the portfolio, ranked #24.
Marshall & Sullivan first reported a position in TMO in Q2 2013 and has held it in 50 quarters since. The position peaked at $6.62M in Q4 2021. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Marshall & Sullivan held 8,876 shares of Thermo Fisher Scientific worth $4.31M as of Q3 2025.
- Marshall & Sullivan bought 56 Thermo Fisher Scientific shares in Q3 2025, an estimated $26.1K.
- Thermo Fisher Scientific made up 2% of Marshall & Sullivan's portfolio in Q3 2025, its #24 holding.
- Marshall & Sullivan first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 50 quarters since.
- Marshall & Sullivan's Thermo Fisher Scientific position peaked at $6.62M in Q4 2021.
- 2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Marshall & Sullivan's 13F filing for Q3 2025, filed 15 Oct 2025.